RA Capital Management - IKENA ONCOLOGY INC ownership

IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 43 filers reported holding IKENA ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
RA Capital Management ownership history of IKENA ONCOLOGY INC
ValueSharesWeighting
Q4 2021$9,405,000
-0.6%
750,0000.0%0.17%
+26.7%
Q3 2021$9,465,000
-10.1%
750,0000.0%0.13%
-22.5%
Q2 2021$10,530,000
-50.3%
750,0000.0%0.17%
-47.0%
Q1 2021$21,188,000750,0000.32%
Other shareholders
IKENA ONCOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,249,123$9,738,7038.94%
CHI Advisors LLC 2,180,934$9,443,4453.74%
Atlas Venture Life Science Advisors, LLC 5,018,178$21,728,7113.36%
ACUTA CAPITAL PARTNERS, LLC 551,010$2,385,8731.60%
Vida Ventures Advisors, LLC 225,192$975,0811.51%
BVF INC/IL 3,169,164$13,722,4800.37%
Artal Group S.A. 1,849,513$8,0080.34%
Orbimed Advisors 3,186,166$13,796,0990.29%
OUP Management Co., LLC 26,833$116,1870.26%
Avoro Capital Advisors LLC 1,640,000$7,101,2000.11%
View complete list of IKENA ONCOLOGY INC shareholders